Concepedia

Lauren R. Blankenship

LR

12

Publications

403

Citations

10

H-Index

2019

Active since

Affiliations

Texas A&M University(Current)

Lawrence Berkeley National Laboratory

The University of Texas Medical Branch at Galveston

Sorrento Therapeutics (United States)

University of North Texas

Lauren R. Blankenship is an author at Texas A&M University specializing in medicine, drug discovery, and virology.

ORCID

Top concepts

Publications per year

2019–2024

12

Publications

12

A Quick Route to Multiple Highly Potent SARS‐CoV‐2 Main Protease Inhibitors**

Kai S. Yang, R. Xinyu, Yuying Ma et al. · ChemMedChem · 2020 · 128 citations · Full text

Discovery of First-in-Class PROTAC Degraders of SARS-CoV-2 Main Protease

Yugendar R. Alugubelli, Jing Xiao, Kaustav Khatua et al. · Journal of Medicinal Chemistry · 2024 · 56 citations · Full text

A systematic exploration of boceprevir-based main protease inhibitors as SARS-CoV-2 antivirals

Yugendar R. Alugubelli, Zhi Geng, Kai S. Yang et al. · European Journal of Medicinal Chemistry · 2022 · 45 citations · Full text

, , +8

A multi-pronged evaluation of aldehyde-based tripeptidyl main protease inhibitors as SARS-CoV-2 antivirals

Yuying Ma, Kai S. Yang, Zhi Geng et al. · European Journal of Medicinal Chemistry · 2022 · 38 citations · Full text

, , +7

Self-Masked Aldehyde Inhibitors: A Novel Strategy for Inhibiting Cysteine Proteases

Linfeng Li, Balachandra Chenna, Kai S. Yang et al. · Journal of Medicinal Chemistry · 2021 · 31 citations · Full text

Rows per page

1–5 of 12